文献速递生殖医学

多囊卵巢综合征患者中ZBTB16变异的验证

Verification of a ZBTB16 variant in polycystic ovary syndrome patients.
PubMed 文献 · Reprod Biomed Online · 2020-05-19

本研究在汉族女性中开展病例对照研究,纳入526例多囊卵巢综合征(PCOS)患者和522例对照,检测rs1784692多态性。结果显示该位点次要等位基因C对PCOS具有保护作用(OR 0.556),但在PCOS患者中与BMI升高相关。

要点

  • rs1784692次要等位基因C对汉族女性PCOS具有保护作用(OR 0.556)。
  • 在PCOS患者中,CC+CT组平均BMI高于TT组(27.12 vs 24.57)。
  • CC+CT组平均LH浓度低于TT组,在PCOS和对照中均如此。

核心结论

  • ZBTB16基因rs1784692多态性与汉族女性PCOS风险降低相关,但在PCOS患者中与BMI升高相关。

研究设计与样本

  • 病例对照研究,纳入526例PCOS患者和522例汉族女性对照,采用TaqMan MGB探针法对rs1784692进行基因分型,并使用显性和加性模型进行基因型-表型关联分析。

主要发现

  • rs1784692次要等位基因C对PCOS具有保护作用(OR 0.556,95%CI 0.408-0.759,P=1.83×10-4),校正BMI和年龄后仍显著(ORadj 0.539,95%CI 0.391-0.743,Padj=1.62×10-4)。
  • 显性模型分析显示,PCOS组中CC+CT组平均BMI高于TT组(27.12±5.82 vs 24.57±4.52,P=1.0×10-3),对照组中无此差异。
  • CC+CT组平均LH浓度低于TT组,PCOS组为9.33±5.08 vs 10.93±5.91(P=0.036),对照组为4.39±1.66 vs 4.89±2.07(P=0.021)。
  • 加性模型分析显示,PCOS患者中TC组平均BMI高于TT组(27.14±5.81 vs 24.57±4.52,P=3.06×10-3)。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RESEARCH QUESTION: This study investigated whether rs1784692 is a risk factor for polycystic ovary syndrome (PCOS) in Han Chinese women. DESIGN: A case-control study was conducted in Han Chinese women, involving 526 PCOS patients and 522 control participants. A TaqMan MGB probe assay was used to genotype the variant rs1784692. Dominant and additive models were employed for genotype-phenotype association analysis in the PCOS and control samples. RESULTS: The minor allele C of rs1784692 is protective against PCOS (odds ratio [OR] 0.556, 95% confidence interval [CI] 0.408-0.759, P = 1.83 × 10-4), even after adjustment for body mass index (BMI) and age (ORadj 0.539, 95% CI 0.391-0.743, Padj= 1.62 × 10-4). Genotype-phenotype analysis of the dominant model showed that mean BMI in the CC+CT group was higher than in the TT group in the PCOS group (27.12 ± 5.82 versus 24.57 ± 4.52, P = 1.0 × 10-3), but not in the control groups, indicating that the minor allele C of rs1784692 associates with BMI in women with PCOS. The mean LH (luteinizing hormone) concentration in the CC+CT group was lower than in the TT group in PCOS and control participants (9.33 ± 5.08 versus 10.93 ± 5.91, P = 0.036; 4.39 ± 1.66 versus 4.89 ± 2.07, P = 0.021). Genotype-phenotype analysis of additive model showed that mean BMI in TC group was higher than in the TT group in PCOS patients compared with control participants (27.14 ± 5.81 versus 24.57 ± 4.52, P = 3.06 × 10-3). CONCLUSIONS: The SNP rs1784692 in gene ZBTB16 is protective against PCOS but is associated with increased BMI in Han Chinese women with PCOS.

来源:Reprod Biomed Online,查看原文。版权归原作者所有。

引用

  1. Yang J, Zhao R, Li L, et al. Verification of a ZBTB16 variant in polycystic ovary syndrome patients. Reprod Biomed Online. 2020. PMID: 32773339. doi:10.1016/j.rbmo.2020.05.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。